loadpatents
name:-0.0071959495544434
name:-0.0063009262084961
name:-0.0013790130615234
ZIMMER; Aline Patent Filings

ZIMMER; Aline

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZIMMER; Aline.The latest application filed is for "cell culture media comprising keto acids".

Company Profile
2.7.6
  • ZIMMER; Aline - Gross-Gerau DE
  • Zimmer; Aline - Gross Genau N/A DE
  • Zimmer; Aline - Massy FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cell Culture Media Comprising Keto Acids
App 20220204918 - ZIMMER; Aline ;   et al.
2022-06-30
Method for reducing the trisulfide level in proteins
Grant 11,220,668 - Zimmer January 11, 2
2022-01-11
Method for increasing the glutathione level in cells
Grant 10,626,364 - Zimmer
2020-04-21
Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy
Grant 10,190,166 - Moingeon , et al. Ja
2019-01-29
Method For Increasing The Glutathione Level In Cells
App 20180216061 - ZIMMER; Aline
2018-08-02
Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa
Grant 9,822,185 - Batard , et al. November 21, 2
2017-11-21
Use Of Igg1 Immunoglobulins And/or Ligands Of The Cd32 Receptor For Treating Inflammatory Diseases And Incidents Via The Mucosa
App 20160032018 - Batard; Thierry ;   et al.
2016-02-04
Use of IgG.sub.1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route
Grant 9,187,568 - Batard , et al. November 17, 2
2015-11-17
Methods For Identifying Dendritic Cell Subsets, For Determining If A Patient Is Developing A Regulatory Or An Effector Immune Response, And For Determining Response To Immunotherapy
App 20140377761 - Moingeon; Philippe ;   et al.
2014-12-25
Use Of Igg1 Immunoglobulins And/or Ligands Of The Cd32 Receptor For Treating Inflammatory Diseases And Manifestations Via The Mucosal Route
App 20120171198 - Batard; Thierry ;   et al.
2012-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed